Gerard Evan

GROUP LEADER -

Although cancers are very diverse and heterogenous, they are nonetheless underpinned by a limited ensemble of shared, common processes. The hope is that identifying and understanding such underlying commonalities will lead to novel cancer therapies that may be broadly applied to diverse patients and many cancer types. 

Gerard obtained his BA in Biochemistry from the University of Oxford in 1977 and his Ph.D. in 1981 in molecular immunology from the MRC Laboratory of Molecular Biology at the University of Cambridge. From 1982-4, he was a post-doctoral fellow with J. Michael Bishop at the University of California San Francisco studying the molecular biology of cancer, returning to take up a Research Fellowship at Downing College Cambridge and Assistant Membership of the Ludwig Institute for Cancer Research. In 1988, he moved to the Imperial Cancer Research Fund Laboratories in London as a Senior, then Principal, Scientist.

He was elected to EMBO and to the Royal Society’s Napier Research Professorship in 1996 and to fellowship of the Academy of Medical Sciences in 1999. That same year he took up a Distinguished Chair in Cancer Biology at the University of California San Francisco and was appointed Professor of Pathology in 2007. In 2009 he returned to the UK to become Sir William Dunn Professor and Head of Biochemistry at the University of Cambridge. In 2022, Gerard joined the Francis Crick Institute and was appointed Professor of Cancer Biology at Kings College London.

Qualifications and history

1977
University of Oxford
B.A. Biochemistry (1st Class)
1981
University of Oxford
M.A.
1981
University of Cambridge (King’s College) & MRC Laboratory of Molecular Biology
Ph.D. Molecular Immunology
1982-1984
University of California, San Francisco
Medical Research Council Traveling Fellow
1984-1988
University of Cambridge, Ludwig Institute for Cancer Research
Assistant Member
1984-1987
Downing College, Cambridge
Research Fellow
1988-1991
Imperial Cancer Research Fund
Senior Scientist
1991-1999
Imperial Cancer Research Fund
Principal Scientist
1996-1999
University College, London
Royal Society Napier Research Professor
1999-2009
University of California San Francisco
Gerson and Barbara Bass Bakar Distinguished Professor of Cancer Biology | Professor of Molecular and Cellular Pharmacology
2007-2012
University of California San Francisco
Professor of Pathology
2009-2022
University of Cambridge
Sir William Dunn Professor of Biochemistry and Head of Department of Biochemistry
2022
Francis Crick Institute
Principal Group Leader
2022
Kings College London
Professor of Cancer Biology